563 related articles for article (PubMed ID: 2107253)
1. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat.
Issekutz TB
J Immunol; 1990 Mar; 144(6):2140-6. PubMed ID: 2107253
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat.
Issekutz TB; Wykretowicz A
J Immunol; 1991 Jul; 147(1):109-16. PubMed ID: 1711066
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1.
Issekutz TB
J Immunol; 1992 Nov; 149(10):3394-402. PubMed ID: 1358970
[TBL] [Abstract][Full Text] [Related]
4. Effect of a monoclonal antibody to VLA-4 on lymphocyte adherence to microvascular and aortic endothelial cells.
Wykretowicz A; Issekutz TB
J Mol Cell Cardiol; 1993 Apr; 25(4):469-75. PubMed ID: 8340936
[TBL] [Abstract][Full Text] [Related]
5. IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1.
Masinovsky B; Urdal D; Gallatin WM
J Immunol; 1990 Nov; 145(9):2886-95. PubMed ID: 1698865
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
Issekutz TB; Stoltz JM; vd Meide P
J Immunol; 1988 May; 140(9):2989-93. PubMed ID: 3129506
[TBL] [Abstract][Full Text] [Related]
7. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma.
Issekutz AC; Issekutz TB
J Immunol; 1993 Aug; 151(4):2105-15. PubMed ID: 8345197
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo.
Issekutz TB
J Immunol; 1991 Dec; 147(12):4178-84. PubMed ID: 1753094
[TBL] [Abstract][Full Text] [Related]
9. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta.
May MJ; Ager A
Eur J Immunol; 1992 Jan; 22(1):219-26. PubMed ID: 1346111
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
Thornhill MH; Wellicome SM; Mahiouz DL; Lanchbury JS; Kyan-Aung U; Haskard DO
J Immunol; 1991 Jan; 146(2):592-8. PubMed ID: 1702807
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines.
Chin YH; Cai JP; Johnson K
J Immunol; 1990 Dec; 145(11):3669-77. PubMed ID: 2123224
[TBL] [Abstract][Full Text] [Related]
12. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1.
Sikorski EE; Hallmann R; Berg EL; Butcher EC
J Immunol; 1993 Nov; 151(10):5239-50. PubMed ID: 7693807
[TBL] [Abstract][Full Text] [Related]
13. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.
Thornhill MH; Haskard DO
J Immunol; 1990 Aug; 145(3):865-72. PubMed ID: 1695647
[TBL] [Abstract][Full Text] [Related]
14. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR
J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes.
Chin YH; Cai JP; Xu XM
J Immunol; 1992 Feb; 148(4):1106-12. PubMed ID: 1737929
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.
Doukas J; Pober JS
J Immunol; 1990 Sep; 145(6):1727-33. PubMed ID: 1697308
[TBL] [Abstract][Full Text] [Related]
17. T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells.
Thornhill MH; Kyan-Aung U; Lee TH; Haskard DO
Immunology; 1990 Feb; 69(2):287-92. PubMed ID: 2106485
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
19. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1.
Hughes CC; Male DK; Lantos PL
Immunology; 1988 Aug; 64(4):677-81. PubMed ID: 3139550
[TBL] [Abstract][Full Text] [Related]
20. Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide.
Miossec P; Ziff M
J Immunol; 1986 Nov; 137(9):2848-52. PubMed ID: 3093584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
